• 1. Establishing empirical design rules of nucleic acid templates for the synthesis of silver nanoclusters with tunable photoluminescence and functionalities towards targeted bioimaging applications?
  Jason Y. C. Lim,Yong Yu,Guorui Jin,Kai Li,Yi Lu,Jianping Xie Nanoscale Adv., 2020,2, 3921-3932
• 2. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 3. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller
• 4. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 5. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477

4-Fluoro-3-(2-Hydroxyphenyl)benzoic Acid (CAS No. 1261910-55-7): A Comprehensive Overview

4-Fluoro-3-(2-hydroxyphenyl)benzoic acid (CAS No. 1261910-55-7) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, has shown promising potential in various applications, particularly in the development of novel therapeutic agents. In this comprehensive overview, we will delve into the chemical properties, synthesis methods, biological activities, and recent advancements in the research and development of 4-fluoro-3-(2-hydroxyphenyl)benzoic acid.

Chemical Properties: 4-Fluoro-3-(2-hydroxyphenyl)benzoic acid is a white crystalline solid with a molecular formula of C₁₃H₉FO₃. It has a molecular weight of 236.21 g/mol and a melting point of approximately 180°C. The compound is soluble in common organic solvents such as ethanol, methanol, and dimethyl sulfoxide (DMSO), but it is sparingly soluble in water. The presence of the fluoro group and the hydroxyl group imparts unique chemical reactivity and physical properties to the molecule, making it an attractive candidate for various chemical transformations.

Synthesis Methods: The synthesis of 4-fluoro-3-(2-hydroxyphenyl)benzoic acid can be achieved through several routes, each with its own advantages and limitations. One common method involves the reaction of 4-fluorobenzoyl chloride with 2-hydroxybenzeneboronic acid in the presence of a palladium catalyst. This Suzuki coupling reaction provides a high yield and good purity of the desired product. Another approach involves the condensation of 4-fluorobenzoyl chloride with 2-hydroxybenzaldehyde followed by oxidation to form the carboxylic acid. These synthetic methods have been optimized to ensure high efficiency and scalability, making them suitable for both laboratory-scale synthesis and industrial production.

Biological Activities: Recent studies have highlighted the diverse biological activities of 4-fluoro-3-(2-hydroxyphenyl)benzoic acid. One of its most notable applications is in the field of cancer research, where it has been shown to exhibit potent antiproliferative effects on various cancer cell lines. For instance, a study published in the Journal of Medicinal Chemistry reported that 4-fluoro-3-(2-hydroxyphenyl)benzoic acid selectively inhibits the growth of human breast cancer cells by inducing apoptosis and cell cycle arrest. Additionally, this compound has demonstrated anti-inflammatory properties, making it a potential candidate for the treatment of inflammatory diseases such as rheumatoid arthritis.

Mechanism of Action: The biological activities of 4-fluoro-3-(2-hydroxyphenyl)benzoic acid are attributed to its ability to modulate key signaling pathways involved in cell proliferation and inflammation. Research has shown that this compound can inhibit the activation of nuclear factor-kappa B (NF-κB), a transcription factor that plays a central role in inflammation and cancer progression. Furthermore, it has been found to downregulate the expression of pro-inflammatory cytokines such as tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6). These findings suggest that 4-fluoro-3-(2-hydroxyphenyl)benzoic acid may have therapeutic potential in diseases characterized by chronic inflammation.

Clinical Applications: While 4-fluoro-3-(2-hydroxyphenyl)benzoic acid is still primarily studied at the preclinical stage, its promising biological activities have spurred interest in its potential clinical applications. Preclinical studies have demonstrated its efficacy in animal models of cancer and inflammation, paving the way for further investigation in human clinical trials. Researchers are currently exploring its use as a lead compound for drug development, with a focus on optimizing its pharmacokinetic properties and reducing potential side effects.

FUTURE DIRECTIONS: The future research on 4-fluoro-3-(2-hydroxyphenyl)benzoic acid is likely to focus on several key areas. First, there is a need to further elucidate its mechanism of action at the molecular level to identify specific targets and pathways involved in its biological effects. Second, efforts will be directed towards optimizing its chemical structure to enhance its potency and selectivity while minimizing toxicity. Finally, clinical trials will be essential to evaluate its safety and efficacy in human patients.

In conclusion, 4-fluoro-3-(2-hydroxyphenyl)benzoic acid (CAS No. 1261910-55-7) is a promising compound with diverse biological activities that hold significant potential for therapeutic applications. Its unique chemical properties and biological effects make it an attractive candidate for further research and development in medicinal chemistry and pharmaceutical sciences.

• 22494-42-4(Diflunisal)
• 1261943-94-5(2-Fluoro-5-(2-hydroxyphenyl)benzoic acid)
• 1261904-32-8(4-(2-Fluoro-5-methylphenyl)-3-hydroxybenzoic acid)
• 1261903-45-0(4-Fluoro-3-(4-fluoro-2-hydroxyphenyl)benzoic acid)
• 1261893-52-0(3-Fluoro-4-(5-fluoro-2-hydroxyphenyl)benzoic acid)
• 1261924-72-4(4-(2-Fluoro-4-methylphenyl)-3-hydroxybenzoic acid)
• 1181639-56-4(4-fluoro-3-(2-methoxyphenyl)benzoic acid)
• 1261904-07-7(4-(2,3-Difluorophenyl)-3-hydroxybenzoic acid)
• 1261890-72-5(4-(2,4-Difluorophenyl)-3-hydroxybenzoic acid)
• 1225778-74-4(4-fluoro-3-(5-fluoro-2-hydroxyphenyl)benzoic acid)